To include your compound in the COVID-19 Resource Center, submit it here.

PR Pharma, SurModics deal

SurModics acquired the drug delivery assets of PR Pharmaceuticals for $3 million up

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE